O'Neill Gilmore Neil 4
4 · Editas Medicine, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
O'Neill Gilmore Neil
DirectorCEO
Transactions
- Sale
Common Stock
2024-06-04$5.50/sh−12,191$66,997→ 315,279 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.